Skip to main content
Caplight Logo









MORF-Bio

MORF-Bio

Private
YorkHealthcare & Life Scienceshttps://morf-bio.com/

Last Round

Pre Seed

Oct 6, 2025

Momentum

Top 25%

of companies Caplight tracks

Company Overview

MORF-Bio is a biotechnology software company that provides a web-based platform for multi-scale fermentation and multi-omics data visualisation.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Vertical SaaS, Low-Code/No-Code, Drug Discovery, Sustainable Materials

Business Model

B2B

Customer Profile

Subscription SaaS, Services & Consulting, Freemium

AI Layer

Application

Keywords

no-code bioinformaticsmulti-omics analysisbioinformatics platformbiotech SaaSfermentation data analysismetabolic modelingmicrobial genome analysisbioprocess data analysisflux balance analysisFBAbiomanufacturing softwarestrain engineeringbioinformatics consultancybioprocess digital twin

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

MORF-Bio Comparables

Compare MORF-Bio with similar companies based on industry and business-model similarity.

MORF-Bio comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Pluto Biosciences
83%
Basepair Inc
78%
BioReact
78%

MORF-Bio Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Pre SeedOct 6, 2025

Key People

Founding team and executive leadership

Joyce Bennett

Chief Executive Officer

Executive Team

Vicki Springthorpe

Chief Technology Officer

Executive Team

MORF-Bio Investors

Notable investors and investment history

MORF-Bio investors
InvestorRounds
York AngelsPre Seed
Deeptech Seed FundPre Seed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 25, 2026

    Monthly visitors grew 38% MoM.

  • May 17, 2026

    Monthly visitors increased 820% MoM, reaching 2K.

MORF-Bio Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

MORF-Bio Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about MORF-Bio's valuation, stock price, and market status.

Firmographic Details

HeadquartersYork
Employee Range8
Year Founded2025
Last FundingOct 6, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?